Characteristic | Bone Mineral Density | |||
---|---|---|---|---|
Lumbar Spine | Total Hip | |||
rho | p | rho | p | |
Age, yrs | −0.48 | < 0.001 | –0.44 | < 0.001 |
Body mass index, kg/m2 | 0.17 | 0.05 | 0.33 | < 0.001 |
Years since menopause | −0.47 | < 0.001 | –0.40 | < 0.001* |
Duration of RA, yrs | −0.12 | 0.10 | 0.19 | 0.03* |
Global functional status (range I–IV) | −0.06 | 0.40 | −0.21 | 0.01* |
HAQ-DI score (range 0–3) | 0.00 | 0.9 | −0.12 | 0.10 |
Joint tenderness count (range 0–28) | 0.12 | 0.10 | 0.01 | 0.80 |
Joint swelling count (range 0–28) | 0.17 | 0.05* | 0.01 | 0.80 |
Prednisone, mg/day | −0.06 | 0.40 | −0.17 | 0.05 |
Rheumatoid factor, IU/ml | −0.10 | 0.30 | 0.23 | 0.02* |
C-reactive protein, mg/l | 0.13 | 0.20 | 0.04 | 0.70 |
Erythrocyte sedimentation rate, mm/h | 0.24 | 0.01* | 0.21 | 0.01* |
Serum leptin, ng/ml | 0.17* | 0.04* | 0.21* | 0.01* |
Correlations were computed using Spearman’s correlation test (rho).